Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro Acquisition
Gilead Sciences is buying Ouro Medicines, a startup creating T cell engagers for a variety of autoimmune illnesses. Individually, Gilead ...
Gilead Sciences is buying Ouro Medicines, a startup creating T cell engagers for a variety of autoimmune illnesses. Individually, Gilead ...
Gilead Sciences and Arcellx have been collaborating on the a number of myeloma cell remedy anito-cel since 2022. This remedy ...
Top of the morning to you, and a fine one it is. Blue skies and comfortable breezes are enveloping the ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.BERLIN — ...
A patient advocacy group is suing the Trump administration for failing to disclose details of a recent settlement with Gilead ...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your ...
Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with ...
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to ...
Gilead Sciences is voluntarily withdrawing cancer drug Trodelvy from the U.S. market as a treatment for advanced cases of urothelial ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.